We delivered controlled radiofrequency (RF) energy to the airways of anesthetized, ventilated dogs to examine the effect of this treatment on reducing airway narrowing caused by a known airway constrictor. The airways of 11 dogs were treated with a specially designed bronchial catheter in 3 of 4 lung regions. Treatments in each of the 3 treated lung regions were controlled to a different temperature (55°C, 65°C, and 75°C); the untreated lung region served as a control. We measured airway responsiveness to local methacholine chloride (MCh) challenge before and after treatment and examined post-treatment histology to 3 years. Treatments controlled to 65°C as well as 75°C persistently and significantly reduced airway responsiveness to local MCh challenge (p ≤
INTRODUCTION
Airway smooth muscle (ASM) contraction is know to cause airway narrowing in mammalian species. In humans with asthma, this may be associated with morbidity and, at times, mortality (1) . Accordingly, blockade of ASM contractility is a primary target of therapy with short-and long-acting bronchodilator medications (2, 3) . However, the ability to block airway narrowing in human subjects with asthma is not always satisfactory, exacerbations are largely unpredictable (4) , and excessive airway narrowing that is not responsive to conventional medications does occur. A therapy that directly and persistently reduces the ability of the airways to narrow would address a major component of asthma exacerbations. This study was undertaken in dogs to determine the effect of temperature controlled radiofrequency (RF) treatment (Alair TM System; Asthmatx, Inc., Mountain View, CA) on the ability of airways to narrow in response to methacholine chloride (MCh).
We hypothesized that we could determine a dose of temperature controlled RF energy capable of reducing the amount of functional ASM in the airway wall, with limited persistent changes to other airway tissues, and thereby attenuate the responsiveness of airways to a known brochoconstrictor, MCh. Therapeutic RF energy is used in a number of treatment modalities, such as in the treatment of cardiac conduction defects in electrophysiology (5). High energy RF technology has been employed in the lung as an ablative treatment for cancer (6) . However, there has been no information available regarding the effect of the much lower energy RF treatment presented here on the bronchoconstrictor response of airways. In these studies, we examined specifically the effects of transient application of relatively low thermal energy to determine if airway smooth muscle could be blocked selectively without significant alteration of adjacent airway tissues.
This study examined the short and long-term effects of the application of RF energy to the airways at three different temperature settings in healthy mongrel dogs.
Parameters measured included the extent of altered ASM (as a percent of the airway circumference) present in the airway wall (as determined through histology) and the responsiveness of treated and control airways to local MCh challenge (as determined by bronchoscopic measurement). The data show that temperature controlled RF treatment of the airways can reduce both the amount of functional ASM in the airway wall and the responsiveness of the airways to local MCh challenge, and that these two effects are correlated.
MATERIALS AND METHODS
This study, using 11 healthy mongrel dogs at the University of Utah Animal weeks post-treatment. Dogs were sacrificed for necropsy and histology according to prospective randomization; 2 at 1 week, and 3 at each of the 6, 12, and 157 week time points. Thoracic radiographs were repeated prior to sacrifice. Observers remained blinded to treatment/control group assignments throughout follow-up bronchoscopies, at necropsy, and for initial histological analysis.
Resting airway diameter and airway responsiveness to local MCh challenge was measured at discrete sites within the bronchial tree, which were carefully mapped and recorded. These mapped, recorded sites served as both baseline and post-treatment follow-up sites for the duration of the study and were later excised for histological analysis. Mapping of sites involved the counting of side branch/daughter airways, and, where necessary, annotated diagrams of the bronchoscopic view. Before MCh challenge, the resting airway diameter was measured using the application catheter as a visual reference (7) . The application catheter is 1.1 mm in diameter, with six radial holes at the distal tip, similar to that described by Brown and Mitzner (8 In all dogs, the lungs were divided into four regions: upper left, lower left, upper right, and lower right; three of these received treatment at 55°C, 65°C, or 75°C, and the remaining region was not treated. The treatment temperatures chosen were in the range used in RF electro-surgical tissue coagulation (9). The treatment and control regions for the dogs were assigned so that there were equal distributions of treatment groups (control, For the purpose of this study, altered ASM was defined as portions of ASM that were degenerative, absent, or replaced by plump, spindle shaped fibroblasts. For each site, the pathologist, on an enlarged print of the slide, indicated the airway circumference containing altered ASM as observed using light microscopy. From this annotated enlarged print, the percent of altered ASM in each slide was estimated.
An analysis of variance (10) was used to establish the statistical significance of the variation in resting airway diameters (airway diameters while not under MCh) over the course of the study. The responsiveness of airways to local MCh challenge was evaluated by analysis of covariance with baseline responsiveness measurements as a covariate (10) . Each of these analyses identified timepoints where statistically significant results were obtained, but do not identify which treatment/control groups differed. At timepoints with significant results, Dunnett's multiple comparison procedure (11) determined differences between each treatment group and control. Significance was claimed when p < 0.05.
RESULTS
All results are presented as mean ± SE.
A total of 11 dogs were treated according to the study protocol. In the study of a 12 th dog, an RF generator malfunction at the time of treatment prevented completion of the protocol. All data from this dog were excluded. In total, over 300 individual airway sites in 11 dogs were examined and over 900 total examinations were made during the course of this 3-year study. Table   1 gives a summary of the mean airway responsiveness data for all treatment groups and the control group over the course of the study. The extent of the treatment effect on ASM was estimated based on the percentage of the overall airway perimeter containing altered ASM. The effect of treatment was confined to the airway wall and the immediate peri-bronchial region, was circumferential in nature, and was not generally localized to the points of contact of the electrode basket, i.e. localized areas of treatment patterned to the catheter geometry were not seen. The percent circumference of the airway with altered ASM generally increased as the treatment temperature increased (Table 2 ). This trend was observed in histology at all sacrifice time points.
Estimates of the extent of altered ASM through histology and corresponding bronchoscopic measurements of airway responsiveness to local MCh challenge measured immediately prior to sacrifice were available for 175 follow-up sites mapped at baseline. There were isolated instances of retained mucus at follow-up sites that was not easily removed by suction. At the week 1 follow-up time 4 dogs had a single 75°C treated airway with retained mucus and one dog had a single 65°C treated airway with retained mucus. There were no occurrences of retained mucus in any airway, at any treatment temperature, at the 6-week follow-up time or later, with the exception of one instance of retained mucus at 157 weeks, observed in a 75°C-treated airway. There were no occurrences of retained mucus at 55°C or control sites.
DISCUSSION
The objective of this investigation was to determine the effect of the application of temperature controlled RF energy to the airways of dogs. We also tested the hypothesis that reductions in ASM caused by RF energy delivery would correlate inversely to the magnitude of airway responsiveness to local MCh challenge. In this investigation, we found that reduction in ASM was related directly to reduction in airway responsiveness to MCh ( Figure 5 ).
Persistent reductions in ASM were observed as a result of treatment. Altered ASM was present as early as 1 week in all treatment groups and the extent of airway circumference containing altered ASM increased at all time points as the treatment temperature increased from 55°C to 75°C. The decrease in airway responsiveness to local MCh challenge was also dependent upon treatment temperature. Airway responsiveness was significantly decreased at 8 of 9 time points following treatment at 65°C and at all time points following treatment at 75°C whereas treatment at 55°C caused a significant decrease at only 1 of 9 time points; week 1 ( Figure 2 ). The reductions in airway responsiveness observed in the 65°C and 75°C treated airways persisted to 3 years following treatment (Figures 2 & 3) .
The inverse correlation between the amount of altered ASM and the airway responsiveness to local MCh challenge does not by itself indicate causation. We suggest that the reduction in the amount of normal ASM observed histologically may result from thermal denaturation of ASM proteins, their subsequent necrosis, and replacement with a thin layer of collagen matrix. As ASM contraction is known to directly cause airway narrowing, we conclude that the reduction in ASM resulting from treatment likely leads to the observed reduction in airway responsiveness.
By analyzing the data with and without sites identified as mis-mapped, we found that the conclusion of a statistically significant correlation between the reduction in ASM and responsiveness holds regardless of the treatment of these sites in the analysis.
Because omission of the mis-mapped sites has not affected the statistical significance of the results and because of a high degree of confidence in our ability to identify mismapped sites, we have presented only the data from the excised sites that we believe to have been accurately identified during excision. While it is possible that we may remove some of the observed variability in airway diameters by using the atropine-relaxed state to determine the pre-challenge airway size, or by using other techniques such as CT to measure airway sizes, both of these add operational challenges when taking the large number of measurements performed here. Nonetheless, the treatment effect size observed here was sufficient to conclude through comparison of blinded observations of treated and untreated airways that the reduced airway responsiveness to local MCh challenge following treatment was statistically significant.
Dogs tolerated the treatment well. There were no adverse physiological or clinical observations made and the stability of airway diameter and maintenance of airway patency is supported by the more than 900 blinded bronchoscopic observations made over the course of the 3-year study. One dog in a separate study was euthanized more than 2 years post-procedure because of acute bronchopneumonia. An extensive pathological examination established that this was an acute event caused by a betahemolytic streptococcal infection. Evidence of this infection was found in four additional dogs in the colony. All of these dogs were successfully treated with antibiotics. The wide separation in time between the procedure and the pneumonia strongly suggests that these two events were unrelated.
It is important to consider the limitations of our findings. This study was performed in dogs, which did not have and do not develop bronchial asthma. ASM was reduced in these dogs without evidence of regeneration, but the degree to which human ASM can regenerate is unknown. We note that RF alteration of ASM was inversely correlated with bronchial hyperresponsiveness, an effect that persisted for up to 3 years (Figures 2 and 3) . A goal of these early investigations is to determine the potential applicability of these finding to therapy for human asthma. Three specific issues underlie the potential applicability of these findings to a human study: 1) Asthma must involve significant ASM contraction in larger (> 3 mm) airways of the lung; 2) The potential role of inflammation, especially in small airways that were not treated in this study, must be considered; and 3) ASM must not play a fundamental or necessary homeostatic role in the regulation of airway function, such that attenuation of its function might cause predisposition to other problems not immediately anticipated from the data obtained in these studies.
There is considerable evidence that ASM in the larger (> 3mm) In contrast to the studies of Hutcheon et al., Fairshter and Wilson (17) demonstrated by the same technique that the predominant sites of bronchodilation causing improvement of airflow in human asthmatics to be the central airways of the lung (proximal to bronchioles). As the larger airways are in series with the smaller airways of the lung, it is expected that the ability to attenuate narrowing in larger airways will, in any circumstance, lessen overall airflow obstruction. The importance of the larger airways in asthma is further supported by recent studies which demonstrate empirically that constriction and closure of segmental and sub-segmental airways of the human lung play a significant role in reducing ventilation in asthma (18) . While the data presented here suggests that airway narrowing and closure might be attenuated by RF treatment of the airways, it remains to be seen whether this treatment could produce a physiologically relevant improvement in airflow during whole-lung challenge.
The classical physiological data designating larger airways as the exclusive site of for a total vestigial function of ASM in humans (25) . As these studies merely establish parameters for approaching such studies in humans, further consideration is beyond the scope of the data presented here. While inflammation and mucus secretion clearly play a large role in asthma (26, 27) , bronchial hyperresponsiveness is another important pathological feature of the disease (28) . Accordingly, the ability to attenuate airway hyperresponsiveness in humans could improve the control of asthma. Such treatment could be of particular benefit to patients with moderate-to-severe asthma.
In summary, our data indicate that applying temperature controlled RF energy to the conducting airways of the lung reduces canine ASM and that the extent of this reduction in ASM correlates inversely to the bronchoconstrictor response to MCh. While it is not possible to extrapolate these findings directly to human asthma, our data suggest a potential approach for the development of a treatment for asthma. Values of airway responsiveness (the percent reduction in airway diameter following local methacholine chloride [MCh] challenge as compared to the pre-MCh challenge diameter) are means ± SE. The number of observations made at each follow-up time is shown for each treatment / control group. The decline in the numbers of observations over the course of the study is a result of sacrifice for histology. Values of percent of airway circumference with altered airway smooth muscle (ASM) are means ± SE. Altered ASM is defined as ASM that is degenerative, absent, or replaced by plump, spindle shaped fibroblasts.
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